ACQUIRED T-CELL SPECIFIC DEFICIENCY OTHER THAN ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS)

被引:6
作者
SAIKI, O
OGAWA, H
IKEDA, T
MASUNO, T
TANAKA, T
DEGUCHI, Y
ENDOU, T
KISHIMOTO, S
机构
[1] Third Department of Internal Medicine, Osaka University School of Medicine, Osaka
关键词
ID DIFFERENT FROM AIDS;
D O I
10.2169/internalmedicine.31.11
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Evidence of an acquired T cell-specific deficiency distinct from acquired immunodeficiency syndrome (AIDS) in a 63-yr-old Japanese female is provided. Recently, this patient suffered from primary invasive pulmonary aspergillosis. Skin tests to purified protein derivative of tuberculin (PPD) and Aspergillus antigens were negative. Upon admission to our hospital, her lymphocytes were exclusively unresponsive to T cell mitogens (concanavalin A, phytohemagglutinin, and OKT 3). The level of cells defined by monoclonal antibodies (CD1, CD2, CD3, CD4, WT31, and CD5) was less than 3%. In contrast, no decrease in the number of red blood cells, platelets, neutrophils or B cells was apparent. Five years ago, the patient had a normal white blood cell and lymphocyte count. However, over the following 4 yr, she developed lymphopenia. With medication, her pulmonary disease recovered, while lymphopenia still continued. The levels of immunoglobulins, complements and enzyme activities (adenosine deaminase and purine nucleoside phosphorylase) were normal. Moreover, several tests for HIV (ELISA and Western bolt) were negative suggesting that the T cell-specific deficiency was not a congenital immunodeficiency or AIDS but rather a new type of acquired immunodeficiency.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 29 条
[1]  
Gottlieb M.S., Schroff R., Schanker H.M., Weisman J.D., Wolf R., Saxon A., Pneumocystis carinii pneumonia and mucosal candidasis in previously healthy homosexual men: Evidence for a new acquired cellular immunodeficiency, N Engl J Med, 305, (1981)
[2]  
Masur H., Michelis M.A., Greene J.B., Et al., An outbreak of community-acquired pneumocystis carinii pneumonia, N Engl J Med, 305, (1981)
[3]  
Barre-Sinoussi F., Chermann J.C., Rey F., Et al., Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS), Science, 220, (1983)
[4]  
Gallo R.C., Sarin P.S., Gelmann E.P., Et al., Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS), Science, 220, (1983)
[5]  
Wong-Staal F., Gallo R.C., Human T-lymphotropic retroviruses, Nature, 317, (1985)
[6]  
Klatzman D., Barre-Sinoussi F., Nugeyre M.T., Et al., Selective tropism of lymphoadenopathy associated virus (LAV) for helper-inducer T lymphocytes, Science, 225, (1984)
[7]  
Fauci A.S., The human immunodeficiency virus: Infectivity and mechanism of pathogenesis, Science, 239, (1988)
[8]  
Fahey J.L., Prince H., Weaver M., Et al., Quantitative changes in T helper or T suppressor/cytotoxic lymphocytes subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders, Am J Med, 76, (1984)
[9]  
Lane H.C., Depper J.M., Greene W.C., Whalen G., Waldmann T.A., Fauci A.S., Qualitative analysis of immune function in patients with acquired immunodeficiency syndrome, N Engl J Med, 313, (1985)
[10]  
Ruscetti R.W., Mikovits J.A., Kalyanaraman U.S., Et al., Analysis of effector mechanisms against HTLV-I and HTLV III/LAV-infected lymphoid cells, J Immunol, 136, (1986)